NDC properties for NDC 9 54723-011
NDC item 54723001101
| NDC 9 | 54723-011 |
|---|---|
| NDC 10 | 54723-011-01 |
| NDC Item | 54723001101 |
| packaging | 3 mL in 1 PACKET (54723-011-01) |
| FDA SPL set id | 704771 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
NDC item 54723001401
| NDC 9 | 54723-014 |
|---|---|
| NDC 10 | 54723-014-01 |
| NDC Item | 54723001401 |
| packaging | 3 mL in 1 PACKET (54723-014-01) |
| FDA SPL set id | 724403 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH NOT FINAL |
| Marketing effective time low | 2023-03-31 |
| Marketing status | ACTIVE |
| OTC monograph not final | part348 |
NDC item 54723001701
| NDC 9 | 54723-017 |
|---|---|
| NDC 10 | 54723-017-01 |
| NDC Item | 54723001701 |
| packaging | 3 mL in 1 PACKET (54723-017-01) |
| FDA SPL set id | 785305 |
| Labeler | Sambria Pharmaceuticals, LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2023-09-26 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |